EUVIMEDEUVIMED entdecken
Crossref

AAV2-mediated ABD-FGF21 gene delivery produces a sustained anti-hyperglycemic effect in type 2 diabetic mouse

Sen-Lin Lu, Zhi-Hao Pan, Zhi Cui, Ji-Li Wang, Jian-Lin Yang, Ya-Feng Lv, Chun-Yu Cao, Xiao-Fei Huang

Life Sciences · 2025

DOI: 10.1016/j.lfs.2024.123344 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Life Sciences, 2025. Verfasst von Sen-Lin Lu und 7 weiteren Autor:innen. Beteiligte Einrichtung: College of Medicine and Health Sciences, China Three Gorges University, Yichang 443002, China; Hubei Key Laboratory of Tumor Microenvironment and Imm…. Hauptthemen laut MEDLINE: Fibroblast Growth Factors, Diabetes Mellitus, Type 2, Dependovirus, Genetic Therapy. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 46 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Fibroblast Growth Factor 21 (FGF21) is a naturally occurring peptide hormone involved in the regulation of glycolipid metabolism, and it shows promise as a potential treatment for type 2 diabetes mellitus (T2DM). However, the short half-life and poor pharmacokinetics of native FGF21 limit its efficacy in reducing hyperglycemia in vivo. Therefore, maintaining stable and sustained blood concentrations of FGF21 is crucial for its role as an effective regulator of glycolipid metabolism in vivo. In this study, we developed an AAV2-mediated gene delivery system incorporating an Albumin-binding domain (ABD) fused to FGF21, and we evaluated its effects in a type 2 diabetic mouse model. METHODS: The plasmids pAAV-FGF21-Luciferase, pHelper, and the capsid plasmid were transfected into HEK293T cells to generate recombinant AAV (rAAV) virus. A type 2 diabetes mellitus (T2DM) mouse model was established for evaluation. The rAAV was administered via tail vein injection into the mice. The effects of rAAV injection on various parameters were assessed using commercial kits. Histological changes in the liver and adipose tissue of T2DM mice were examined using hematoxylin and eosin (H&E) staining. RESULTS: The data showed that the inclusion of ABD significantly prolonged the half-life of FGF21 in the serum of mice. Additionally, AAV2-mediated delivery of ABD-FGF21 to the liver resulted in sustained gene expression and a significant increase in circulating FGF21 levels in mice. Treatment with AAV2-ABD-FGF21 led to several benefits, including reduced fasting glucose, improved insulin sensitivity, decreased triglyceride and total cholesterol levels, and improved body weight in T2DM mice. Furthermore, serum analysis and histological examination showed no significant liver damage at the study endpoint after seven weeks. CONCLUSION: In conclusion, we have developed a novel strategy for producing long-acting FGF21 using the AAV vector, and AAV2-ABD-FGF21 shows promise as a therapeutic approach for type 2 diabetes mellitus and other glycolipid metabolic disorders.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fibroblast Growth FactorsDiabetes Mellitus, Type 2DependovirusGenetic TherapyGene Transfer TechniquesDiabetes Mellitus, ExperimentalHypoglycemic AgentsAnimalsMiceHumansMaleHEK293 CellsMice, Inbred C57BLGenetic VectorsBlood Glucose

Stichwörter der Autor:innen

Adeno-associated virus type 2Albumin-binding domainFibroblast Growth Factor 21Type 2 diabetes mellitus

Substanzen

Fibroblast Growth Factorsfibroblast growth factor 21Hypoglycemic AgentsBlood Glucose

Autor:innen und Institutionen

  • College of Medicine and Health Sciences, China Three Gorges University, Yichang 443002, China; Hubei Key Laboratory of Tumor Microenvironment and Immunotherapy, China Three Gorges University, Yichang 443002, China.
  • Hubei Key Laboratory of Tumor Microenvironment and Immunotherapy, China Three Gorges University, Yichang 443002, China; College of Basic Medical Sciences, China Three Gorges University, Yichang 443002, China.
  • Hubei Key Laboratory of Tumor Microenvironment and Immunotherapy, China Three Gorges University, Yichang 443002, China; College of Basic Medical Sciences, China Three Gorges University, Yichang 443002, China. Electronic…
  • College of Medicine and Health Sciences, China Three Gorges University, Yichang 443002, China; Hubei Key Laboratory of Tumor Microenvironment and Immunotherapy, China Three Gorges University, Yichang 443002, China. Elec…

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Lu, S. L., Pan, Z. H., Cui, Z., Wang, J. L., Yang, J. L., Lv, Y. F., Cao, C. Y., & Huang, X. F. (2025). AAV2-mediated ABD-FGF21 gene delivery produces a sustained anti-hyperglycemic effect in type 2 diabetic mouse. Life Sciences. https://doi.org/10.1016/j.lfs.2024.123344

Vancouver

Lu SL, Pan ZH, Cui Z, Wang JL, Yang JL, Lv YF, et al. AAV2-mediated ABD-FGF21 gene delivery produces a sustained anti-hyperglycemic effect in type 2 diabetic mouse. Life Sciences. 2025. doi:10.1016/j.lfs.2024.123344

BibTeX
@article{Lu2025,
  author = {Lu, Sen-Lin and Pan, Zhi-Hao and Cui, Zhi and Wang, Ji-Li and Yang, Jian-Lin and Lv, Ya-Feng and Cao, Chun-Yu and Huang, Xiao-Fei},
  title = {AAV2-mediated ABD-FGF21 gene delivery produces a sustained anti-hyperglycemic effect in type 2 diabetic mouse},
  journal = {Life Sciences},
  year = {2025},
  doi = {10.1016/j.lfs.2024.123344}
}
Kostenlos starten →